In dermatology, patients with nodosum leprosum and discoid lupus erythematosus are benefited by clofazimine therapy. Its use in other autoimmune diseases has to be considered. Patients with lupus pernio may respond to this regime, but further prolonged trials will have to be undertaken.
No takes yet. Share an insight, caveat, or question.
J. P. Mackey (1976) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: